Partitioning and structural effects of the antitumor drug daunomycin on model membranes.

[1]  B. de Kruijff,et al.  Transport of the anti-cancer drug doxorubicin across cytoplasmic membranes and membranes composed of phospholipids derived from Escherichia coli occurs via a similar mechanism. , 1996, Biochimica et biophysica acta.

[2]  J. S. Hyde,et al.  Depth dependence of the perturbing effect of placing a bulky group (oxazolidine ring spin labels) in the membrane on the membrane phase transition. , 1996, Biochimica et biophysica acta.

[3]  N. Nelson,et al.  Functional analysis of conserved cysteine residues in the catalytic subunit of the yeast vacuolar H(+)-ATPase. , 1994, Biochimica et biophysica acta.

[4]  W. Subczynski,et al.  Partitional and motional properties of a spin-labeled daunomycin in lipid bilayers. An ESR study. , 1992, Journal of inorganic biochemistry.

[5]  J. González-Ros,et al.  Different distribution of daunomycin in plasma membranes from drug-sensitive and drug-resistant P388 leukemia cells. , 1992, Biochimica et biophysica acta.

[6]  F. Frézard,et al.  DNA-containing liposomes as a model for the study of cell membrane permeation by anthracycline derivatives. , 1991, Biochemistry.

[7]  J. González-Ros,et al.  Role of membrane lipids in the interaction of daunomycin with plasma membranes from tumor cells: implications in drug-resistance phenomena. , 1990, Biochemistry.

[8]  J. Boggs,et al.  Lipid intermolecular hydrogen bonding: influence on structural organization and membrane function. , 1987, Biochimica et biophysica acta.

[9]  R. Brasseur,et al.  Study of the adriamycin-cardiolipin complex structure using attenuated total reflection infrared spectroscopy. , 1987, Biochemistry.

[10]  J. Vanderkooi,et al.  Anthracycline binding to synthetic and natural membranes. A study using resonance energy transfer. , 1986, Biochemistry.

[11]  P. Vrignaud,et al.  Fluorescence anisotropy of cell membranes of doxorubicin-sensitive and -resistant rodent tumoral cells. , 1986, Cancer research.

[12]  W. Vaz,et al.  Effect of short-chain primary alcohols on fluidity and activity of sarcoplasmic reticulum membranes. , 1986, Biochemistry.

[13]  J. S. Hyde,et al.  Spin-label studies on phosphatidylcholine-cholesterol membranes: effects of alkyl chain length and unsaturation in the fluid phase. , 1986, Biochimica et biophysica acta.

[14]  J. Bolard,et al.  Interaction of adriamycin with negatively charged model membranes: evidence of two types of binding sites. , 1985, Biochemistry.

[15]  T. Burke,et al.  Location and dynamics of anthracyclines bound to unilamellar phosphatidylcholine vesicles. , 1985, Biochemistry.

[16]  L. Liu,et al.  Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. , 1984, Science.

[17]  A. Ramu,et al.  Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells. , 1983, Cancer research.

[18]  H. Triebel,et al.  Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: geometry of intercalation of iremycin and daunomycin. , 1982, Biochemistry.

[19]  G. Yee,et al.  The anticancer agent adriamycin can be actively cytotoxic without entering cells. , 1982, Science.

[20]  A. Sartorelli,et al.  Adriamycin-induced changes in the surface membrane of sarcoma 180 ascites cells. , 1981, Biochimica et biophysica acta.

[21]  M. Dalmark.  Characteristics of doxorubicin transport in human red blood cells. , 1981, Scandinavian journal of clinical and laboratory investigation.

[22]  R. Ozols,et al.  The anthracycline antineoplastic drugs. , 1981, The New England journal of medicine.

[23]  E. Goormaghtigh,et al.  Evidence of a complex between adriamycin derivatives and cardiolipin: possible role in cardiotoxicity. , 1980, Biochemical pharmacology.

[24]  S. Schulman,et al.  Electronic absorption spectra and protolytic equilibria of doxorubicin: direct spectrophotometric determination of microconstants. , 1977, Journal of pharmaceutical sciences.

[25]  H. Mcconnell,et al.  Lateral phase separation in phospholipid membranes. , 1973, Biochemistry.

[26]  T. Koch,et al.  Redox chemistry of anthracycline antitumor drugs and use of captodative radicals as tools for its elucidation and control. , 1991, Chemical research in toxicology.

[27]  T. Koch,et al.  Leucodaunomycins, new intermediates in the redox chemistry of daunomycin , 1991 .